CAR T-cell Therapy Market Size, Share & Trends Report

CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi), By Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-090-4
Number of Pages: 90
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

CAR T-cell Therapy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Abecma (idecabtagene vicleucel)
- Breyanzi (lisocabtagene maraleucel)
- Carvykti (ciltacabtagene autoleucel)
- Kymriah (tisagenlecleucel)
- Tecartus (brexucabtagene autoleucel)
- Yescarta (axicabtagene ciloleucel)
- Others
CAR T-cell Therapy Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Leukemia
- Lymphoma
- Multiple Myeloma
- Others
CAR T-cell Therapy End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Cancer Treatment Centers
CAR T-cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - The U.S.
    - U.S. CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - U.S. CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - U.S. CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
  - Canada
    - Canada CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - Canada CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - Canada CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
- Europe
  - UK
    - UK CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - UK CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - UK CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
  - Germany
    - Germany CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - Germany CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - Germany CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
- Asia Pacific
  - Japan
    - Japan CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - Japan CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - Japan CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
  - China
    - China CAR T-cell Therapy Market, by Product, 2018 - 2030
      - Abecma
      - Breyanzi
      - Carvykti
      - Kymriah
      - Tecartus
      - Yescarta
      - Others
    - China CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
      - Leukemia
      - Lymphoma
      - Multiple Myeloma
      - Others
    - China CAR T-cell Therapy Market, by End-Use, 2018 - 2030
      - Hospitals
      - Cancer Treatment Centers
- ROW
  - ROW CAR T-cell Therapy Market, by Product, 2018 - 2030
    - Abecma
    - Breyanzi
    - Carvykti
    - Kymriah
    - Tecartus
    - Yescarta
    - Others
  - ROW CAR T-cell Therapy Market, by Disease Indication, 2018 - 2030
    - Leukemia
    - Lymphoma
    - Multiple Myeloma
    - Others
  - ROW CAR T-cell Therapy Market, by End-Use, 2018 - 2030
    - Hospitals
    - Cancer Treatment Centers

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.